(Q53940865)
Statements
Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia (English)
Chengyuan Xue
Luciano Dalla Pozza
Michael J Brisco
Glenn M Marshall
Edward Kwan
Ling Zhu
Daniella Ferrara
Alexander Morley
Boyd Webster